Security key
696389402
PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI)
CUSIP: 696389402
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.01 per share
- Shares outstanding
- 177,984,636
- Total 13F shares
- 30,078
- Share change
- +30,078
- Total reported value
- $135,352
- Price per share
- $4.50
- Number of holders
- 7
- Value change
- +$135,352
- Number of buys
- 7
Report period
Q2 2024
Institutions
7
Top holders
8
PALI full security history
Newer quarter: Q3 2024
PALISADE BIO, INC. SEC filings
PALISADE BIO, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 696389402
Recent filing periods:
Top shareholders of PALI - PALISADE BIO, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Yuma Regional Medical Center |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,814,375
|
$925,331 | — | 19 Aug 2021 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
—
class O/S missing
|
720,000
|
$287,352 | — | 31 Mar 2024 | |
| Thomas Hallam |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
137,592
mixed-class rows
|
$29,372 | — | 16 Aug 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
68,054
|
$27,160 | — | 31 Mar 2024 | |
| Marex Group plc |
13F
|
Company |
—
class O/S missing
|
35,759
|
$14,271 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
34,448
|
$13,748 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
—
class O/S missing
|
32,326
|
$12,000 | — | 31 Mar 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
—
class O/S missing
|
28,208
|
$11,258 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
22,463
|
$8,965 | — | 31 Mar 2024 | |
| Michael John Dawson |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
15,000
|
$7,650 | — | 29 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
18,200
|
$7,264 | — | 31 Mar 2024 | |
| Cristina Csimma |
3/4/5
|
Director |
—
mixed-class rows
|
19,742
mixed-class rows
|
$5,609 | — | 08 Feb 2024 | |
| Stephanie Diaz |
3/4/5
|
Director |
—
mixed-class rows
|
19,680
mixed-class rows
|
$5,582 | — | 08 Feb 2024 | |
| James R. Neal |
3/4/5
|
Director |
—
mixed-class rows
|
17,800
mixed-class rows
|
$4,762 | — | 09 Feb 2024 | |
| Robert J. Trenschel |
3/4/5
|
Director |
—
mixed-class rows
|
17,800
mixed-class rows
|
$4,762 | — | 08 Feb 2024 | |
| Mary Ann Gray |
3/4/5
|
Director |
—
mixed-class rows
|
12,700
mixed-class rows
|
$2,968 | — | 21 Nov 2023 | |
| Robert Curtis McRae |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
2,588
mixed-class rows
|
$1,320 | — | 03 Apr 2023 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
2,225
|
$887 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
2,108
|
$841 | — | 31 Mar 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
—
class O/S missing
|
1,500
|
$599 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
411
|
$164 | — | 31 Mar 2024 | |
| Orion Capital Management LLC |
13F
|
Company |
—
class O/S missing
|
299
|
$119 | — | 31 Mar 2024 | |
| BFSG, LLC |
13F
|
Company |
—
class O/S missing
|
40
|
$16 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
9
|
$4 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
—
class O/S missing
|
3
|
$1 | — | 31 Mar 2024 |
Institutional Holders of PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI) as of Q2 2024
As of 30 Jun 2024,
PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,078 shares.
The largest 8 holders included
Marex Group plc, ARMISTICE CAPITAL, LLC, UBS Group AG, Tower Research Capital LLC (TRC), MORGAN STANLEY, Federation des caisses Desjardins du Quebec, WELLS FARGO & COMPANY/MN, and BANK OF AMERICA CORP /DE/.
This page lists
8
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q4 2025 Across Filers
Q4 2025 holders
87
Q2 2024 holders
7
Holder diff
-80
| Investor | Q4 2025 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.